Delivery Order SPE2DB22D2006-SPE2DB24FW3MK
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$73K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Bridion 200 mg/2 ml vials to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,754.77 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, to be completed by March 27, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31,...
This federal contract award is for the delivery of Bridion 500 mg/5 ml vial product, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $9,787.92 firm fixed price delivery order contract has a completion date of November 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of Bridion 200 mg/2 ml vial 2 ml to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $21,867.22, is a firm fixed-price delivery order with a completion date of May 29, 2025. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Bridion 200 mg/2 ml vial, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 1, 2024, with a completion date of July 2, 2024. The contract has a firm fixed price of $4,735.69 and is a delivery order. The award is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Bridion 500 mg/5 ml vial 5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $9,345.61 and a period of performance through March 8, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical products to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $10,212.08 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract has an ultimate completion date of February 16, 2024 and is not designated with any set-aside requirements, indicating open...
This federal contract award is a delivery order valued at $8,644.81 issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Bridion 200 mg/2 ml vial, a medical product, with an ultimate completion date of May 23, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds...
This federal contract award is for the delivery of Bridion 200 mg/2 ml vial (2 ml) to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 14, 2025, with a ceiling value of $2,504.08. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 15, 2025. This award does not...
This federal contract award is for the delivery of Bridion 200 mg/2 ml vials to the Defense Logistics Agency (DLA), a major agency within the U.S. Department of Defense. The award, valued at $4,030.17, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, awarded on May 2, 2024, with a completion date of May 3, 2024. The contract does not have a set-aside...
This federal contract award, valued at $7,410.74, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with a performance period running through February 26, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...